BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 34939092)

  • 1. Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Alon L; Corica B; Raparelli V; Cangemi R; Basili S; Proietti M; Romiti GF
    Eur J Prev Cardiol; 2022 May; 29(6):938-946. PubMed ID: 34939092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Bisaccia G; Ricci F; Khanji MY; Sorella A; Melchiorre E; Iannetti G; Galanti K; Mantini C; Pizzi AD; Tana C; Renda G; Fedorowski A; De Caterina R; Gallina S
    Curr Probl Cardiol; 2023 Jun; 48(6):101643. PubMed ID: 36773944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between nonalcoholic fatty liver disease and atrial fibrillation and other clinical outcomes: a meta-analysis.
    Jaiswal V; Ang SP; Huang H; Momi NK; Hameed M; Naz S; Batra N; Ishak A; Doshi N; Gera A; Sharath M; Waleed MS; Raj N; Aguilera Alvarez VH
    J Investig Med; 2023 Aug; 71(6):591-602. PubMed ID: 37002665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review and meta-analysis of cohort studies on the potential association between NAFLD/MAFLD and risk of incident atrial fibrillation.
    Zhou BG; Ju SY; Mei YZ; Jiang X; Wang M; Zheng AJ; Ding YB
    Front Endocrinol (Lausanne); 2023; 14():1160532. PubMed ID: 37476492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis.
    Mantovani A; Dauriz M; Sandri D; Bonapace S; Zoppini G; Tilg H; Byrne CD; Targher G
    Liver Int; 2019 Apr; 39(4):758-769. PubMed ID: 30657626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular outcomes in breast cancer survivors: a systematic review and meta-analysis.
    Galimzhanov A; Istanbuly S; Tun HN; Ozbay B; Alasnag M; Ky B; Lyon AR; Kayikcioglu M; Tenekecioglu E; Panagioti M; Kontopantelis E; Abdel-Qadir H; Mamas MA
    Eur J Prev Cardiol; 2023 Dec; 30(18):2018-2031. PubMed ID: 37499186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of non-alcoholic fatty liver disease and atrial fibrillation: a review.
    Käräjämäki AJ; Hukkanen J; Ukkola O
    Ann Med; 2018 Aug; 50(5):371-380. PubMed ID: 29929399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease increases the risk of cardiovascular disease in young adults and children: a systematic review and meta-analysis of cohort studies.
    Liao YL; Zhu GY; Chang C
    Front Cardiovasc Med; 2023; 10():1291438. PubMed ID: 38268853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany.
    Labenz C; Huber Y; Michel M; Nagel M; Galle PR; Kostev K; Schattenberg JM
    Dig Dis Sci; 2020 Jul; 65(7):2112-2119. PubMed ID: 31797186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults.
    Alexander M; Loomis AK; van der Lei J; Duarte-Salles T; Prieto-Alhambra D; Ansell D; Pasqua A; Lapi F; Rijnbeek P; Mosseveld M; Avillach P; Egger P; Dhalwani NN; Kendrick S; Celis-Morales C; Waterworth DM; Alazawi W; Sattar N
    BMJ; 2019 Oct; 367():l5367. PubMed ID: 31594780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease is associated with a worse prognosis in patients with heart failure: A pool analysis.
    Qiu M; Li J; Hao S; Zheng H; Zhang X; Zhu H; Zhu X; Hu Y; Cai X; Huang Y
    Front Endocrinol (Lausanne); 2023; 14():1167608. PubMed ID: 37152967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between non-alcoholic fatty liver disease and atrial fibrillation: A meta-analysis.
    Wijarnpreecha K; Boonpheng B; Thongprayoon C; Jaruvongvanich V; Ungprasert P
    Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):525-532. PubMed ID: 28866089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation.
    Cai X; Zheng S; Liu Y; Zhang Y; Lu J; Huang Y
    Liver Int; 2020 Jul; 40(7):1594-1600. PubMed ID: 32279432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of cerebral microbleeds and risk of adverse outcomes in atrial fibrillation: a systematic review and meta-analysis.
    Corica B; Romiti GF; Raparelli V; Cangemi R; Basili S; Proietti M
    Europace; 2022 Oct; 24(9):1395-1403. PubMed ID: 35244694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal cancers in lean individuals with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Souza M; Diaz I; Barchetta I; Mantovani A
    Liver Int; 2024 Jan; 44(1):6-14. PubMed ID: 37833849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Alcoholic Fatty Liver Disease (NAFLD) and risk of new-onset heart failure: a retrospective analysis of 173,966 patients.
    Roderburg C; Krieg S; Krieg A; Vaghiri S; Mohr R; Konrad M; Luedde M; Luedde T; Kostev K; Loosen SH
    Clin Res Cardiol; 2023 Oct; 112(10):1446-1453. PubMed ID: 37410163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes.
    Targher G; Mantovani A; Pichiri I; Rigolon R; Dauriz M; Zoppini G; Morani G; Vassanelli C; Bonora E
    Clin Sci (Lond); 2013 Sep; 125(6):301-9. PubMed ID: 23596966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study.
    Lee CH; Han KD; Kim DH; Kwak MS
    Front Endocrinol (Lausanne); 2021; 12():638615. PubMed ID: 33776934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study.
    Pastori D; Sciacqua A; Marcucci R; Del Ben M; Baratta F; Violi F; Pignatelli P;
    Intern Emerg Med; 2021 Nov; 16(8):2063-2068. PubMed ID: 33713286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between non-alcoholic fatty liver disease and cardiac arrhythmia: a systematic review and meta-analysis.
    Gong H; Liu X; Cheng F
    J Int Med Res; 2021 Sep; 49(9):3000605211047074. PubMed ID: 34590877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.